Loading…
EMV Capital’s 2024 results: 67% revenue growth to £2.5m but losses widen to £3.7m. Analysing the investor’s strategic shift amid portfolio expansion.
This article covers information on EMV Capital PLC.
LON:EMVCEMV Capital’s preliminary results for 2024 present a classic growth-stage conundrum: impressive top-line expansion paired with deepening losses. The deep tech and life sciences investor reported a 67% surge in core revenue to £2.0 million, driving group revenue to £2.5 million. Yet losses widened to £3.7 million from £2.9 million in 2023. Let’s dissect what’s really happening beneath these headline numbers.
The revenue story is undoubtedly strong:
But the loss expansion reveals strategic choices:
Critically, EMV maintains a cash position of £1.0 million (up from £0.2 million) with £1.4 million in liquid securities. December’s £1.5 million share placing at a 15% premium provided crucial breathing room.
Here’s where EMV’s strategic pivot shines. Total AUM jumped 33% to £98.5 million, with further growth to £103 million by May 2025. This expansion stems from two key moves:
The Martlet acquisition transformed EMV’s model overnight – adding 40+ companies to its portfolio and establishing a recurring revenue stream with minimal cash outlay.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
54 viewsLikes
No ratings yet
Enjoying this?
Occasional emails on automation, AI and finance. Unsubscribe any time.
EMV’s portfolio now spans 70+ companies, with several approaching inflection points:
Notably, the “venture building programme” continues delivering exceptional returns – generating £8.5 million in fair value uplift from just £0.9 million invested across five companies.
Three strategic pillars define EMV’s evolution:
The full rebrand to EMV Capital in September 2024 cemented this transition from holding company to integrated VC platform.
Management acknowledges near-term challenges while projecting confidence:
Yet CEO Ilian Iliev sees “meaningful opportunity amid disruption,” particularly in defence, industrial reshoring, and healthcare innovation – sectors where EMV has concentrated exposure.
EMV Capital is executing a textbook platform build during arguably the toughest venture environment in a decade. The 67% revenue growth and 33% AUM expansion demonstrate real traction in their model shift toward fund management and recurring fees.
While losses are widening and portfolio markdowns (notably PDS and Q-Bot) hurt, the strategic repositioning looks sound. The key question for investors: Can EMV reach cash flow breakeven before portfolio companies demand further support? With several portfolio stars approaching commercialization and £103m AUM generating fees, the 2025 inflection point could be dramatic.
One to watch closely – especially if the promised “cohort of outsized venture returns” materializes in their defence and deep tech sweet spots.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.